Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Other Non Operating Income (2016 - 2025)

Dare Bioscience (DARE) has disclosed Other Non Operating Income for 10 consecutive years, with $109382.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income rose 617.12% year-over-year to $109382.0, compared with a TTM value of $5309.0 through Sep 2025, up 100.71%, and an annual FY2024 reading of -$981490.0, down 226.08% over the prior year.
  • Other Non Operating Income was $109382.0 for Q3 2025 at Dare Bioscience, up from -$188683.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $369887.0 in Q1 2021 and bottomed at -$732883.0 in Q1 2024.
  • Average Other Non Operating Income over 5 years is $60991.9, with a median of $103350.5 recorded in 2023.
  • The sharpest move saw Other Non Operating Income skyrocketed 39270.32% in 2021, then tumbled 315.46% in 2024.
  • Year by year, Other Non Operating Income stood at $368201.0 in 2021, then decreased by 21.96% to $287344.0 in 2022, then crashed by 60.36% to $113898.0 in 2023, then crashed by 203.78% to -$118201.0 in 2024, then skyrocketed by 192.54% to $109382.0 in 2025.
  • Business Quant data shows Other Non Operating Income for DARE at $109382.0 in Q3 2025, -$188683.0 in Q2 2025, and $202811.0 in Q1 2025.